Steris | STE - Cost Of Sales

Stock Price
225.03
Daily Change
5.81 2.65%
Monthly
-1.18%
Yearly
0.94%
Q2 Forecast
212.13

Steris reported $840.7M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
3M USD 4.08B 283M Dec/2025
Accuray USD 116.17M 14.63M Dec/2024
Avanos Medical USD 94.9M 3.1M Dec/2025
Baxter International USD 2.4B 512M Dec/2025
Becton, Dickinson and Co. USD 2.84B 2.35B Dec/2025
Boston Scientific USD 1.84B 82M Dec/2025
CONMED USD 154.91M 16.9M Dec/2025
Cooper Companies USD 376.8M 87.4M Dec/2025
Dexcom USD 466.9M 11M Dec/2025
Ecolab USD 2.35B 49M Dec/2025
Edwards Lifesciences USD 343M 2.2M Dec/2025
Fortive USD 413.6M 35.7M Dec/2025
Getinge SEK 6.02B 1.7B Dec/2024
Globus Medical USD 290.47M 8.09M Dec/2025
Haemonetics USD 136.58M 4.01M Dec/2025
Hologic USD 463.7M 5.1M Dec/2025
Idexx Laboratories USD 432.46M 10.58M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 215.2M 19M Dec/2025
Integra LifeSciences USD 193.44M 1.62M Dec/2025
Intuitive Surgical USD 961.9M 119.2M Dec/2025
J&J USD 7.97B 689M Dec/2025
Masimo USD 165.2M 24.3M Dec/2025
Olympus JPY 96.15B 9.61B Dec/2025
Orthofix International USD 66.63M 6.4M Dec/2025
Owens Minor USD 436.92M 32.62M Dec/2025
ResMed USD 555.85M 29.13M Dec/2025
Steris USD 840.7M 26.3M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 261.54M 199.84M Dec/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025